Logo image of IMMX

IMMIX BIOPHARMA INC (IMMX) Stock Analyst Ratings

USA - NASDAQ:IMMX - US45258H1068 - Common Stock

4.21 USD
+0.6 (+16.62%)
Last: 11/14/2025, 8:00:01 PM
4.2999 USD
+0.09 (+2.14%)
After Hours: 11/14/2025, 8:00:01 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to IMMX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 93.82% above the current price.
IMMX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IMMX.
In the previous month the buy percentage consensus was at a similar level.
IMMX was analyzed by 7 analysts. More opinions would make the average more meaningful.
IMMX Historical Analyst RatingsIMMX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -36 -33 -30 -27 -24 -21 -18 -15 -12 -9 -6 -3 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 4.218.088.168.168.40 - 91.92% 93.82% 93.82% 99.52%
IMMX Current Analyst RatingIMMX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-09-12 HC Wainwright & Co. Maintains Buy -> Buy
2025-06-04 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-10 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-19 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-26 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-07-01 HC Wainwright & Co. Initiate Buy
2023-08-14 Roth MKM Reiterate Buy -> Buy
2023-02-22 Roth MKM Initiate Buy

IMMIX BIOPHARMA INC / IMMX FAQ

Can you provide the average price target for IMMIX BIOPHARMA INC stock?

7 analysts have analysed IMMX and the average price target is 8.16 USD. This implies a price increase of 93.82% is expected in the next year compared to the current price of 4.21.


How do analysts rate IMMIX BIOPHARMA INC (IMMX)?

The consensus rating for IMMIX BIOPHARMA INC (IMMX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.